Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
BNTX
BNTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest BNTX ETF News Today | Earnings, Events & Price Alerts
BNTX News
CDC Meeting to Address Vaccine Injuries and Long COVID
5d ago
seekingalpha
BioNTech Sues Moderna Over Patent Issues
Feb 23 2026
Yahoo Finance
Top Performing Large-Cap Stocks Last Week
Feb 22 2026
Benzinga
Walmart's Guidance Falls Short of Expectations
Feb 19 2026
CNBC
BioNTech SE Stock Downgraded by Leerink Partners
Feb 19 2026
Yahoo Finance
Moderna's Flu Vaccine Receives FDA Review Approval
Feb 18 2026
CNBC
BioNTech (BNTX.US) Executive Plans to Sell $93.87 Million in Common Stock via Form 144
Feb 12 2026
moomoo
Pfizer Shares Decline Despite Strong Earnings: Concerns for Wall Street.
Feb 03 2026
Barron's
Oncolytics Biotech Strengthens Leadership Amid Oncology Market Surge
Jan 28 2026
PRnewswire
Oncolytics Biotech Strengthens Leadership to Advance Clinical Programs
Jan 28 2026
Newsfilter
Investment Strategy Analysis for Biotech Stocks
Jan 27 2026
Fool
Analysis of FBT Stock's 52-Week High and Low Points
Jan 27 2026
NASDAQ.COM
HHS Secretary Robert F. Kennedy Jr. Dismisses Four Childhood Vaccine Advisors, Impacting Vaccine Injury Compensation Program
Jan 20 2026
seekingalpha
Goldman Sachs Upgrades BioNTech (BNTX) to Buy, Raises Price Target to $142
Jan 16 2026
stocktwits
Stocks to Consider Buying in 2026: Insights from Our Roundtable Experts, Including DoorDash and LVMH
Jan 16 2026
Barron's
Deutsche Bank Upgrades Coupang to Buy, Strong Regulatory Resilience
Jan 16 2026
CNBC
Show More News
